NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
GLAXOSMITHKLINE PHARMACEUTICALS LTD. (BSE: 500660)
500660 Technical Analysis
1
As on 28th Mar 2024 500660 SHARE Price closed @ 1943.10 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
500660SHARE Price
Open | 1888.45 | Change | Price | % |
High | 1963.15 | 1 Day | N/A | N/A |
Low | 1888.45 | 1 Week | 0.00 | 0.00 |
Close | 1943.10 | 1 Month | 0.00 | 0.00 |
Volume | 18731 | 1 Year | 0.00 | 0.00 |
52 Week High 0.00 | 52 Week Low 0.00 |
BSE INDIA Most Active Stocks
532822 | 13.24 | % |
532775 | 1.60 | % |
532648 | 23.20 | % |
517001 | 0.09 | 12.50% |
512379 | 14.18 | % |
532667 | 40.47 | % |
507878 | 11.21 | % |
532368 | 13.78 | % |
511389 | 7.25 | -2.42% |
534690 | 7.65 | 4.79% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
500660 Daily Charts |
500660 Intraday Charts |
Whats New @ Bazaartrend |
500660 Free Analysis |
|
500660 Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
500660 Target March 2024
4th UP Target | 0 |
3rd UP Target | 0 |
2nd UP Target | 0 |
1st UP Target | 0 |
1st DOWN Target | 0 |
2nd DOWN Target | 0 |
3rd DOWN Target | 0 |
4th DOWN Target | 0 |
500660 Weekly Target
4th UP Target | 0.00 |
3rd UP Target | 0.00 |
2nd UP Target | 0.00 |
1st UP Target | 0.00 |
1st DOWN Target | 0.00 |
2nd DOWN Target | 0.00 |
3rd DOWN Target | 0.00 |
4th DOWN Target | 0.00 |
500660 Target2024
4th UP Target | 0 |
3rd UP Target | 0 |
2nd UP Target | 0 |
1st UP Target | 0 |
1st DOWN Target | 0 |
2nd DOWN Target | 0 |
3rd DOWN Target | 0 |
4th DOWN Target | 0 |
GLAXOSMITHKLINE PHARMACEUTICALS LTD. ( BSE INDIA Symbol : 500660 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
500660 Other Details
Segment | EQ | |
Market Capital | 248061296640.00 | |
Sector | Other | |
Industry | Other | |
Offical website | > echo $website ; ?> |
500660 Address
500660 Latest News
500660 Business Profile
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, manufactures, and distributes pharmaceutical products and vaccines worldwide. It offers prescription and non-prescription drugs for asthma, infectious diseases, mental health, digestive conditions, and other diseases; and vaccines for various therapeutic areas, primarily cancer. The company also provides medicinal substances, such as antibiotics, endocrine products, and basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, and its salts and esters; glycosides and vegetable alkaloids; and chemically pure sugar. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 and is headquartered in Mumbai, India. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service